Latest

neuropharmacology

·May 12, 2026·7 min read

GLP-1 Drugs Dramatically Reduce “Food Noise” in Weight Loss

GLP-1 medications effectively "turn down the volume" on intrusive food thoughts. In a study of 417 adults, those combining medication with behavioral therapy saw a significantly greater reduction in "food noise" than those using therapy alone, offering a potential neurobiological explanation for the success of these new obesity treatments.

Featured Neuroscience

·May 7, 2026·9 min read

GLP-1 Drugs Found to Directly Rewire Brain’s Reward System

Researchers have discovered a neural pathway connecting the amygdala to dopamine neurons that allows these weight-loss medications to reduce the desire for rewarding foods, offering a new explanation for their effectiveness and their impact on addictive behaviors.

Featured Neurology Neuroscience Psychology

·April 28, 2026·7 min read

43% of Antipsychotics for Seniors Start in Hospitals

Antipsychotic prescriptions are "sticky," often continuing for over a year after being initiated in hospital settings.

Brain Cancer Featured Neurology Neuroscience

·April 20, 2026·6 min read

Exercise and Ibuprofen May Shield Against Chemo Brain

A Phase II trial finds that walking and resistance exercise, along with low-dose ibuprofen, can protect cancer patients from "chemo brain" during treatment.

Autism Featured Neuroscience

·April 20, 2026·8 min read

Study Links Sterol-Inhibiting Drugs to Autism Risk

Astudy of 6 million births links common medications that inhibit cholesterol synthesis, including certain antidepressants and beta-blockers—to a 1.47-fold increased risk of autism.

This shows a woman on a scale with people pointing at her.

Featured Neuroscience Psychology

·April 17, 2026·8 min read

Decoding the Shame Associated with Ozempic Weight Loss

Women using GLP-1 drugs for weight loss face higher levels of stigma than those using diet and exercise, with many critics viewing the medication as a "shortcut."

Featured Neurology Neuroscience Pain

·April 16, 2026·8 min read

The Brain Circuitry of Placebo Pain Relief

Researchers have pinpointed the brain's "placebo circuit." By training the brain to release its own endorphins in the vlPAG region, they achieved broad-spectrum pain relief without the need for addictive drugs.

This shows an older man's nose surrounded by a mist.

Featured Neurology Neuroscience

·April 14, 2026·10 min read

Nasal Spray Reverses Brain Aging and Inflammation

A new two-dose nasal spray reverses brain aging by delivering microRNAs directly to the brain. The therapy reduces "neuroinflammation" and restores memory within weeks.

Featured Neuroscience

·April 13, 2026·5 min read

Enriched Environments Could Blunt Opioid Addiction

New research shows that environmental enrichment reduces fentanyl intake and prevents stress-induced relapse by lowering stress hormones, offering a scalable strategy for addiction treatment.

Featured Neurology Neuroscience

·April 11, 2026·7 min read

Parkinson’s Meds Accidentally Trigger Bacteria to “Eat” Levodopa

How does gut bacteria affect Parkinson’s medication? COMT inhibitors trigger the growth of E. faecalis, which metabolizes levodopa before it can reach the brain.

Featured Neurology Neuroscience

·April 9, 2026·7 min read

Micronutrients Could Stop Brain Bleeding in Alzheimer’s Treatment

Researchers have found that combining Alzheimer’s medications with molecules derived from grapes and turmeric is more effective and safer than current treatments, potentially reducing risks of brain swelling.

Featured Genetics Neuroscience

·April 8, 2026·8 min read

Ozempic Weight Loss Success Varies by DNA

A new study of 28,000 people identifies genetic markers in the GLP1R and GIPR genes that explain why some patients lose more weight or experience more nausea on GLP-1 drugs.